Voriconazole topical cream formulation: evidence for stability and antifungal activity.
Fusarium solani
Voriconazole
fungi
skin infection
stability
topical
Journal
International journal of antimicrobial agents
ISSN: 1872-7913
Titre abrégé: Int J Antimicrob Agents
Pays: Netherlands
ID NLM: 9111860
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
received:
09
04
2020
revised:
22
06
2020
accepted:
05
07
2020
pubmed:
14
7
2020
medline:
20
5
2021
entrez:
14
7
2020
Statut:
ppublish
Résumé
Systemic use of voriconazole (VCZ) might be restricted by adverse events, such as hepatotoxicity and neurotoxicity, or drug-drug interactions. Topical VCZ application to skin may help to treat local infection more effectively and limit unwanted whole-body exposure. Topical VCZ cream was stable for 90 days when refrigerated. A patient with cutaneous Fusarium solani infection on his right forearm was successfully treated with topical 1% VCZ cream after failure of oral VCZ treatment.
Identifiants
pubmed: 32659465
pii: S0924-8579(20)30253-3
doi: 10.1016/j.ijantimicag.2020.106083
pii:
doi:
Substances chimiques
Antifungal Agents
0
Voriconazole
JFU09I87TR
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
106083Informations de copyright
Copyright © 2020 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.